Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Tongji Pharmaceutical is a China-based pharmaceutical manufacturer focused primarily on chemical APIs and related pharmaceutical production. The company appears to operate as a commercial-stage manufacturer rather than a clinical-stage drug developer, with marketed and supply products including metronidazole, troxerutin, trimethoprim, norfloxacin, nitrendipine, nifedipine, amlodipine, vitamin U, and armillarisin A. Public business registry information indicates that it is an active private company headquartered in Ruicheng County, Yuncheng, Shanxi, and engaged in drug manufacturing, commissioned drug production, pharmaceutical wholesale and retail, import/export, and related R&D. Its profile suggests capabilities in API manufacturing, regulatory compliance, and conversion of research into industrial production, with additional activities spanning disinfectants, hygiene products, food additives, and Class I medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Tongji Pharmaceutical.